pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,785 catalysts · 5,159 phase readout · 2,308 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 37 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,159
  • 8k filing2,308
  • pdufa315
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT04450758: Acute Colon Resection Versus Bridge to Colon Surgery With Stent or Stoma

Sponsor: Skane University Hospital. Phase: . Conditions: Colon Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03726658: Zelquistinel in the Treatment of Adults With Major Depressive Disorder

Sponsor: Syndeio Biosciences, Inc. Phase: PHASE1. Conditions: Major Depressive Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT05272826: Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

Sponsor: Canadian Myeloma Research Group. Phase: PHASE2. Conditions: Multiple Myeloma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05934526: Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Sponsor: GB002, Inc.. Phase: PHASE3. Conditions: Pulmonary Arterial Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT07101926: Monitoring of Anti-TFPI in Hemophilia

Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Hemophilia, Rebalancing Agents, Prophylaxis

full page →ctgov ↗
›COMPLETEDphase readoutNCT03283878: Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial

Sponsor: Duke University. Phase: PHASE4. Conditions: Arthropathy of Knee, Antibiotic Prophylaxis

full page →ctgov ↗
›RECRUITINGphase readoutNCT04227678: Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency

Sponsor: Université de Sherbrooke. Phase: NA. Conditions: Lipoprotein Lipase Deficiency

full page →ctgov ↗
›TERMINATEDphase readoutNCT00426985: Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis

Sponsor: APR Applied Pharma Research s.a.. Phase: PHASE3. Conditions: Tendonitis, Bursitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT03832985: Pediatric Reporting of Adult-Onset Genomic Results

Sponsor: Geisinger Clinic. Phase: EARLY_PHASE1. Conditions: Hereditary Breast and Ovarian Cancer Syndrome, Lynch Syndrome, Familial Hypercholesterolemia

full page →ctgov ↗
›TERMINATEDphase readoutNCT04058743: Nickel Sensitivity

Sponsor: Rush University Medical Center. Phase: NA. Conditions: Knee Arthropathy, Allergic Reaction

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06457555: Knowledge Levels and Experiences of Intensive Care Nurses on the Prevention of Pressure Sores: Mixed Method

Sponsor: Burdur Mehmet Akif Ersoy University. Phase: . Conditions: Nurses, Pressure Ulcer, Critical Care

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07451925: Prediction of Postoperative Pain Using Venous Cannulation Pain and Preoperative Anxiety Scores

Sponsor: Fatih Sultan Mehmet Training and Research Hospital. Phase: . Conditions: Preoperative Anxiety, Postoperative Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT03965325: FOcUs on Colorectal CAncer oUtcomes: Long-Term Study

Sponsor: IHU Strasbourg. Phase: . Conditions: Colorectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05066217: An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

Sponsor: Epygenix. Phase: PHASE3. Conditions: Lennox Gastaut Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT06157840: Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD

Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Opioid Use Disorder, Poor Quality Sleep

full page →ctgov ↗
›RECRUITINGphase readoutNCT07487740: A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants

Sponsor: Trevi Therapeutics. Phase: PHASE1. Conditions: Healthy Participants

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04821089: A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

Sponsor: Ipsen. Phase: PHASE1. Conditions: Moderate to Severe Upper Facial Lines

full page →ctgov ↗
›COMPLETEDphase readoutNCT02362750: Evaluating Cancer Survivorship Care Models

Sponsor: George Washington University. Phase: . Conditions: Quality of Life, Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06276491: Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Sponsor: Xencor, Inc.. Phase: PHASE1. Conditions: Ovarian Cancer, Endometrial Cancer, Germ Cell Tumor, Testicular Germ Cell Tumor, Ovarian Germ Cell Tumor

full page →ctgov ↗
›COMPLETEDphase readoutNCT07236918: The Concert Therapy Pilot Study for Stress Reduction and Wellbeing

Sponsor: BeHnam KhodaRahmi. Phase: NA. Conditions: Stress Reduction, Psychological Wellbeing, Mental Health, Music Therapy

full page →ctgov ↗
›COMPLETEDphase readoutNCT03478839: Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)

Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: Generalized Arterial Calcification of Infancy, Autosomal Recessive Hypophosphatemic Rickets Type2

full page →ctgov ↗
›RECRUITINGphase readoutNCT07517575: Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis

Sponsor: R-Pharm International, LLC. Phase: PHASE2. Conditions: Juvenile Idiopathic Arthritis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07528001: Hypno-Breastfeeding Education and Postpartum Outcomes

Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Postpartum Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT06272812: A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region.

Sponsor: International AIDS Vaccine Initiative. Phase: PHASE2. Conditions: Tuberculosis (TB)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07215312: A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin

Sponsor: Eli Lilly and Company. Phase: PHASE2. Conditions: Diabetes Mellitus, Type 2

full page →ctgov ↗
›RECRUITINGphase readoutNCT07290881: Comparing the Postoperative Analgesic Efficacy of Anterior Iliac Block and Ilioinguinal-iliohypogastric Block in Inguinal Hernia Surgery

Sponsor: Harran University. Phase: NA. Conditions: Acute Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06149819: Chest Pain Nurse Track

Sponsor: University Hospital, Grenoble. Phase: NA. Conditions: Chest Pain

full page →ctgov ↗
›WITHDRAWNphase readoutNCT05170828: Cryopreserved MMUD BM With PTCy for Hematologic Malignancies

Sponsor: Ossium Health, Inc.. Phase: PHASE1. Conditions: Acute Leukemia, Myelodysplastic Syndromes, T-lymphoblastic Lymphoma, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic Leukemia, Acute Undifferentiated Leukemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02574728: Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

Sponsor: Emory University. Phase: PHASE2. Conditions: Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06024928: Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes

Sponsor: University of Virginia. Phase: NA. Conditions: Type 2 Diabetes

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07466771: Art Education and Creativity in Midwifery Students

Sponsor: Selcuk University. Phase: NA. Conditions: Creativity and Mindfulness

full page →ctgov ↗
›COMPLETEDphase readoutNCT05040971: Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes

Sponsor: Novo Nordisk A/S. Phase: PHASE3. Conditions: Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06027671: Structured Peer-delivered ART and Reentry Community Strategy

Sponsor: Johns Hopkins University. Phase: NA. Conditions: Retention in Care

full page →ctgov ↗
›RECRUITINGphase readoutNCT06747871: Opioids, Low Nicotine Cigarettes, and Chronic Pain

Sponsor: Duke University. Phase: NA. Conditions: Chronic Pain, Tobacco Use, Opioid Substitution Treatment

full page →ctgov ↗
›COMPLETEDphase readoutNCT03490071: Long-term Follow up of Patients With Longstanding Hip and Groin Pain

Sponsor: Lund University. Phase: . Conditions: Hip Pain Chronic

full page →ctgov ↗
›RECRUITINGphase readoutNCT07185971: PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic Brain Injury, or Brain Surgery

Sponsor: NeuroAEye LLC. Phase: NA. Conditions: Homonymous Hemianopsia, Homonymous Quadrantanopia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06886971: Strategies to AchieVe Viral Suppression for Youth With HIV

Sponsor: Johns Hopkins University. Phase: NA. Conditions: Human Immunodeficiency Virus (HIV) Infection

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07559071: Effects of Emotional Freedom Technique and Music Therapy in High-Risk Pregnancy

Sponsor: Selcuk University. Phase: NA. Conditions: Preterm Premature Rupture of Membranes (PPROM), Premature Rupture of Membranes (PROM), High-Risk Pregnancy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07390344: VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)

Sponsor: W.L.Gore & Associates. Phase: . Conditions: Ascites, Variceal Bleeding, Portal Hypertension Related to Cirrhosis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT02579044: Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria

Sponsor: Boston Children's Hospital. Phase: PHASE1. Conditions: Progeria

full page →ctgov ↗
›RECRUITINGphase readoutNCT07435909: Bupivacaine for Postoperative Pain After Laparoscopic Hysterectomy

Sponsor: Serkan Kumbasar. Phase: NA. Conditions: Postoperative Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07396909: A First-in-Human Single and Multiple Ascending Dose Study of MT-701

Sponsor: Mirador Therapeutics, Inc.. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›RECRUITINGphase readoutNCT00001532: Role of Genetic Factors in the Development of Lung Disease

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Cystic Fibrosis, Pulmonary Fibrosis, Tuberous Sclerosis, Asthma, Pulmonary Sarcoidosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT03645863: Effects of Iron Supplements on the Pharmacokinetics of MT-6548

Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Healthy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07447063: The Impact of Dietary Salt on the Severity of Eczema

Sponsor: University of California, San Francisco. Phase: PHASE4. Conditions: Eczema, Atopic Dermatitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07460687: Westlake Frequent-sampling Cohort

Sponsor: Westlake University. Phase: . Conditions: Health Adults, Stability of Microbiome

full page →ctgov ↗
›RECRUITINGphase readoutNCT06999187: A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Sponsor: Dren Bio. Phase: PHASE1. Conditions: Triple Negative Breast Cancer, HER2-negative Breast Cancer, Non Small Cell Lung Cancer, Cervical Cancer, Castrate Resistant Prostate Cancer, Pancreatic Ductal Adenocarcinoma, Head-and-neck Squamous Cell Carcinoma, Endometrial Cancer, Ovarian Cancer, Gastric Cancer, Gastroesophageal-junction Cancer, Urothelial Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07474987: Portable VR-based Chromatic Pupilloperimeter for Diagnosis and Monitoring of Traumatic Brain Injury

Sponsor: Sheba Medical Center. Phase: . Conditions: Traumatic Brain Injury (TBI) Patients, Healthy Participants, Non-TBI Trauma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06918587: A Comparative Evaluation of Pharmacokinetics and Immunogenicity.

Sponsor: Kashiv BioSciences, LLC. Phase: PHASE1. Conditions: Febrile Neutropenia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07521787: Prognostic Value of Metabolic Characteristics in High-Risk Populations for Acute Kidney Injury After Cardiac Surgery

Sponsor: Shanghai Zhongshan Hospital. Phase: . Conditions: Cardiac Surgery Associated - Acute Kidney Injury, Critical Illness

full page →ctgov ↗
← prev
page 71 of 156
next →